MustGrow Achieves 100% Economical Control Of Panama Disease, Moves To Field Trials
MustGrow Biologics (CSE: MGRO) has seen further validation of its proprietary mustard derived biopesticide following further laboratory results. The latest
Read moreMustGrow Biologics (CSE: MGRO) has seen further validation of its proprietary mustard derived biopesticide following further laboratory results. The latest
Read moreKickstarting our short holiday week for the Daily Dive is that of Colin Bletsky, COO of MustGrow Biologics (CSE: MGRO).
Read moreMustGrow Biologics (CSE: MGRO) has received the results from initial laboratory testing that was conducted in Colombia against the Panama
Read more